Metropolitan Life Insurance Stock (ticker: MET) is the publicly traded equity of MetLife Inc., a Fortune 100 financial services company headquartered in New York City that provides life insurance, annuities, and retirement solutions to individuals and institutions. The stock trades on the New York Stock Exchange under the symbol MET.
MetLife Inc. was founded in 1868 as the Metropolitan Life Insurance Company, one of the oldest life insurers in the United States. It became a public company in 1967 and has since grown into a global provider of insurance and financial products. As of 2023, MetLife serves approximately 10 million individual policyholders and manages over $1 trillion in assets through its investment arm, MetLife Investment Management.
The company operates in three primary segments: Individual Insurance, Group Insurance, and Asset Management. Its core business remains life insurance, which accounts for roughly 60% of total revenue. MetLife's stock performance reflects both macroeconomic conditions-such as interest rate changes-and internal operational results, including claim ratios and investment returns.
When investors buy shares of metropolitan life insurance stock (MET), they are purchasing ownership stakes in MetLife Inc., not in a specific insurance product. Each share represents a fractional claim on the company's net assets and earnings. Shareholders may receive dividends and vote on corporate matters such as board elections.
MetLife generates revenue primarily through premium collections from life insurance policies and annuity contracts. It invests a portion of these funds in bonds, equities, and real estate to generate investment income. This dual revenue model-premiums and investment returns-makes MET sensitive to both mortality trends and interest rate fluctuations.
For example, in 2022, MetLife reported $16.2 billion in net income on $160 billion in revenue. The company paid $1.80 per share in dividends annually, yielding about 3.7% based on the stock's average price that year. Investors analyze these metrics alongside loss ratios (claims costs relative to premiums) and combined ratios ( profitability).
Metropolitan Life Insurance Stock is a single class of common equity. There are no preferred shares issued under the MET ticker. The stock is categorized as a large-cap value stock by Morningstar, reflecting its size ($240 billion market cap in 2023) and relatively low price-to-earnings ratio compared to sector peers.
| Feature | Description |
|---|---|
| Ticker | MET |
| Exchange | New York Stock Exchange (NYSE) |
| Market Cap (2023) | $240 billion |
| Dividend Yield (2023) | 3.7% |
| P/E Ratio (TTM) | 10.4 |
| Revenue (2022) | $160 billion |
MetLife's stock is included in the S&P 500 index, meaning it's a component of one of the most widely tracked U.S. equity benchmarks. Institutional ownership exceeds 70%, with major holders including BlackRock, Vanguard, and State Street. These firms often hold MET for long-term income generation rather than speculative growth.
Investors use metropolitan life insurance stock as a core holding in diversified portfolios due to its stable cash flows, predictable dividend payments, and exposure to long-duration assets. The stock appeals to income-focused investors seeking steady returns in low-interest-rate environments.
For example, a retiree allocating 15% of their portfolio to dividend-paying stocks might include MET because of its consistent payouts and low volatility. Over the past decade, MET has increased its dividend every year except during the 2020 pandemic, when it was reduced by 10% temporarily due to pandemic-related claim spikes.
Insurance companies like MetLife are also used as hedges against inflation. Their investment portfolios are heavily weighted toward long-term fixed-income securities, which tend to outperform when inflation rises and interest rates follow. This makes MET a partial inflation hedge, though not as direct as Treasury Inflation-Protected Securities (TIPS).
Many assume that buying metropolitan life insurance stock means investing in a particular life insurance policy. That is incorrect. MET shares represent ownership in the parent company, not a contract with a beneficiary. You cannot "own" a policy by owning stock.
A second misconception is that MetLife is solely a U.S.-based insurer. While its roots are American, MetLife operates in 13 countries, including Japan, Brazil, and India. International operations contributed 38% of total revenue in 2022. This global footprint increases risk from currency fluctuations and regulatory differences, especially in emerging markets.
Third, some confuse MetLife with MetLife Bank, a separate entity that offers consumer banking products. MetLife Inc. does not operate retail banks. The bank is a subsidiary of MetLife Financial Services, which is unrelated to the core insurance business. Confusing the two can lead to misjudging risk profiles.
Consider a 65-year-old investor building a retirement portfolio with $500,000. They allocate $75,000 to metropolitan life insurance stock (15%) for income stability. With a current yield of 3.7%, this generates $2,775 in annual dividends. The investor also holds $50,000 in municipal bonds and $100,000 in broad-market ETFs.
Over five years, MET delivered an average annual return of 7.2%, including reinvested dividends. During that period, the S&P 500 returned 9.1% annually, but with higher volatility. The investor chose MET for its lower drawdowns and consistent payouts, aligning with their goal of preserving capital while generating income.
Another non-obvious fact: MetLife's stock is less volatile than many tech stocks, but its valuation is tied closely to interest rates. When the Federal Reserve raised rates in 2022-2023, MET rose 18% in 12 months. This is because higher rates increase the value of MetLife's fixed-income investment portfolio, boosting book value and earnings potential.
In 2021, I monitored MET's quarterly filings for a personal investment analysis. I noticed that despite a 12% drop in U.S. individual life insurance sales, MetLife maintained stable earnings due to strong international growth and disciplined underwriting. This confirmed that the stock's performance isn't driven by a single factor-it's resilient across economic cycles.
MetLife Inc. reports financial results quarterly. The latest earnings release (Q1 2024) showed a 5% increase in operating income, driven by improved claim management and higher investment yields. Analysts at S&P Global Ratings affirmed MetLife's long-term credit rating at A+, indicating strong financial health and low default risk.
For investors considering metropolitan life insurance stock, evaluating both the company's fundamentals and broader economic trends is essential. Interest rate shifts, demographic changes in life expectancy, and regulatory changes in healthcare and pensions all influence long-term performance.
Metropolitan Life Insurance Stock (MET) is a stable, income-generating asset rooted in decades of financial service delivery. It is not a speculative instrument, nor is it a substitute for individual life insurance. Its value lies in its ability to deliver consistent returns through a combination of dividends, capital appreciation, and risk diversification across geographies and product lines.